跳至主要内容
临床试验/NCT05095142
NCT05095142已完成不适用

Preventive and Personalized Medicine (2021-2023)

Asfendiyarov Kazakh National Medical University1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2022年3月30日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
500
试验地点
1
主要终点
enotyping for the SNP associated with liver cirrhosis

研究概览

简要总结

The purpose of this study is to identify genetic determinants of susceptibility to idiopathic osteoarthritis of the knee . It will assist in predicting individual risks of disease progression and would help to clarify pathophysiologic mechanisms of idiopathic osteoarthritis of the knee

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
18 Years 至 68 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with bilateral idiopathic gonarthrosis aged 18 to 65 years;
  • Representatives of the Kazakh ethnic group up to the 3rd generation;
  • Hereditary history of arthrosis;
  • Persons who are able and willing to provide written informed consent;

排除标准

  • Patients with bilateral idiopathic gonarthrosis under 18 years of age and over 65 years of age;
  • Representatives of other ethnic groups;
  • Representatives of the Kazakh ethnic group less than 3 generations;
  • No family history of bilateral idiopathic gonarthrosis;
  • Patients with an acute period of the inflammatory process (laboratory and clinical signs);
  • Persons who, in the opinion of the researcher, are mentally or legally incapacitated, which prevents obtaining informed consent;
  • Pregnant or lactating women;
  • Tuberculosis of any localization in the active phase and in history;
  • Severe and decompensated diseases of the liver and kidneys, cardiovascular system;
  • Severe and decompensated course of endocrine diseases;
  • Autoimmune diseases;
  • Systemic diseases;
  • Oncological diseases;

结局指标

主要结局

enotyping for the SNP associated with liver cirrhosis

时间窗: 1 year

Genotype frequency of SNP in the study genes of participants and control participants.

次要结局

未报告次要终点

研究者

发起方
Asfendiyarov Kazakh National Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ildar Fakhradiyev

Head of the Laboratory of Experimental Medicine

Asfendiyarov Kazakh National Medical University

研究点 (1)

Loading locations...

相似试验